SCHEMBL98315

SCHEMBL98315

O=C1NC(=O)C(=Cc2cc(=O)n(Cc3ccc(Cl)cc3)c3ccccc23)S1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.61
MGAM O43451 1/20 0.57
GAA P10253 1/20 0.57
SI P14410 1/20 0.57
MGAM2 Q2M2H8 1/20 0.57
IGF1R P08069 1/20 0.50
PIM1 P11309 1/20 0.50
PIM2 Q9P1W9 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
LMNA P02545 1/20 0.49
PLA2G1B P04054 1/20 0.49
POLB P06746 1/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
ATG4B Q9Y4P1 1/20 0.49
CNR1 P21554 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
TTR P02766 1/20 0.47
AKR1B1 P15121 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98313 1.00 PARP1 (0.61) PARP1MGAMGAASIMGAM2
SCHEMBL97235 0.90 PARP1 (0.58) PARP1MGAMGAASIMGAM2
SCHEMBL97234 0.90 PARP1 (0.58) PARP1MGAMGAASIMGAM2
SCHEMBL8812776 0.83 PARP1 (0.82) PARP1MGAMGAASIMGAM2
SCHEMBL8688578 0.83 PARP1 (0.82) PARP1MGAMGAASIMGAM2
SCHEMBL97231 0.82 MGAM (0.59) PARP1MGAMGAASIMGAM2
SCHEMBL97229 0.82 MGAM (0.59) PARP1MGAMGAASIMGAM2
SCHEMBL96143 0.79 MEN1 (0.56) GAAMEN1KMT2ALMNAPOLB
SCHEMBL8813928 0.78 PARP1 (0.64) PARP1MGAMGAASIMGAM2
SCHEMBL8686629 0.78 PARP1 (0.64) PARP1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 PARP1 3173/4885MGAM 3166/4885GAA 4784/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 PARP1 3173/4885MGAM 3166/4885GAA 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.